Immunosenescence
21
7
8
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 21 trials
100.0%
+13.5% vs benchmark
5%
1 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (21)
Exploratory Study on Infection and Immunosenescence Based on an Elderly Clinical Cohort
COVID-19 Serology and Immunosenescence
Research Project on the Interaction Between Immune Function and Infectious Diseases in Older Adults and the Development of Prevention and Control Strategies
Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial
Interferon Reference for Older People - REFIPA Study
The Impact of Aerobic Exercise Program on Immunosenescence Institutionalized Older Adults
Precision Microbiota Interventions for Senoreduction Trial
Effect of Oral Supplement on Influenza Vaccine Long-term Response
VITAL: Vaccination, Immunity, Time-restricted Eating, Aging and Lifestyle
Biobank and Brain Health in Bordeaux.
The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders.
Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial
The Immu-KNEE-ty Study
Using BCG to Protect Senior Citizens During the COVID-19 Pandemic
Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents
Pyridostigmine as Immunomodulator in People Living With HIV
Fasting-mimicking Diet and Immunosenescence
Effect of Milk Protein and Prebiotics in Combination With Vitamin D on Innate Immunity in Elderly People
Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity
The Effect of Prebiotic B-GOS on the Immune Function, Metabolism and Gut Microbiota of Elderly People